NCT01708044View on ClinicalTrials.gov

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Type 1 Diabetes
Interventions
DRUG

Pramlintide acetate

OTHER

Placebo

Placebo Comparator

Trial Locations (1)

Unknown

Research Site, Portland

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

AstraZeneca

INDUSTRY